These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12074905)

  • 1. Regional decreases in NK-3, but not NK-1 tachykinin receptor binding in dystonic hamster (dt(sz)) brains.
    Friedman Y; Richter A; Raymond R; Löscher W; Nobrega JN
    Neuroscience; 2002; 112(3):639-45. PubMed ID: 12074905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional alterations in neuronal activity in dystonic hamster brain determined by quantitative cytochrome oxidase histochemistry.
    Nobrega JN; Richter A; Jiwa D; Raymond R; Löscher W
    Neuroscience; 1998 Apr; 83(4):1215-23. PubMed ID: 9502259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in dynorphin immunoreactivity but unaltered density of enkephalin immunoreactive neurons in basal ganglia nuclei of genetically dystonic hamsters.
    Kreil A; Hamann M; Sander SE; Richter A
    Synapse; 2011 Nov; 65(11):1196-203. PubMed ID: 21638337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster.
    Nobrega JN; Richter A; Tozman N; Jiwa D; Löscher W
    Neuroscience; 1996 Apr; 71(4):927-37. PubMed ID: 8684623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in AMPA receptor binding in an animal model of inborn paroxysmal dystonia.
    Nobrega JN; Raymond R; Barlow K; Hamann M; Richter A
    Exp Neurol; 2002 Aug; 176(2):371-6. PubMed ID: 12359179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cholecystokinin, somatostatin, thyrotropin-releasing hormone, glutamic acid decarboxylase and tyrosine hydroxylase genes in the central nervous motor systems of the genetically dystonic hamster.
    Burgunder J; Richter A; Löscher W
    Exp Brain Res; 1999 Nov; 129(1):114-20. PubMed ID: 10550508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study.
    Nalivaiko E; Michaud JC; Soubrié P; Le Fur G; Feltz P
    Neuroscience; 1997 Jun; 78(3):745-57. PubMed ID: 9153655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
    Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
    J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative EEG analysis of depth electrode recordings from several brain regions of mutant hamsters with paroxysmal dystonia discloses frequency changes in the basal ganglia.
    Gernert M; Richter A; Rundfeldt C; Löscher W
    Mov Disord; 1998 May; 13(3):509-21. PubMed ID: 9613745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular amino acid levels in the striatum of the dt(sz) mutant, a model of paroxysmal dystonia.
    Hamann M; Sohr R; Morgenstern R; Richter A
    Neuroscience; 2008 Nov; 157(1):188-95. PubMed ID: 18824218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
    Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
    Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
    Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
    Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P.
    Dermon CR; Tzagournissakis M; Savaki HE
    Neuroscience; 1992 Oct; 50(4):795-809. PubMed ID: 1280349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of metabotropic glutamate 5 receptors in the striatum and cortex and effects of modulators on the severity of dystonia in the phenotypic dt
    Perl S; Richter F; Gericke B; Richter A
    Eur J Pharmacol; 2019 Sep; 859():172527. PubMed ID: 31283933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.
    Gernert M; Hamann M; Bennay M; Löscher W; Richter A
    J Neurosci; 2000 Sep; 20(18):7052-8. PubMed ID: 10995851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine hydroxylase immunoreactivity and [3H]WIN 35,428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal dystonia.
    Nobrega JN; Gernert M; Löscher W; Raymond R; Belej T; Richter A
    Neuroscience; 1999; 92(1):211-7. PubMed ID: 10392843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites.
    Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
    Neuroscience; 2003; 116(3):761-73. PubMed ID: 12573718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased adenosine receptor binding in dystonic brains of the dt(sz) mutant.
    Nobrega JN; Barlow KL; Raymond R; Richter A
    Neuroscience; 2005; 134(1):33-8. PubMed ID: 15961243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease.
    Chen LW; Yung KK; Chan YS
    Curr Drug Targets; 2004 Feb; 5(2):197-206. PubMed ID: 15011953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of preproenkephalin and prodynorphin mRNA in a genetic model of paroxysmal dystonia.
    Nobrega JN; Parkes JH; Wong P; Raymond R; Richter A
    Brain Res; 2004 Jul; 1015(1-2):87-95. PubMed ID: 15223370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.